Mucocutaneous leishmaniasis in Australia: A case report

Rationale: Australia is the only inhabited continent, which is not endemic to leishmaniasis. There are some published articles reporting cutaneous leishmaniasis in travellers, immigrants and refugees. However, mucocutaneous leishmaniasis has not been reported previously from the continent. Patient concerns: Lesions were present over the nasal septum and the oropharynx of a 34-year-old healthy non-indigenous male. Diagnosis was delayed as it took multiple biopsies as well as extensive discussions in a multidisciplinary team. Diagnosis: Mucocutaneous leishmaniasis. Interventions: Liposomal Amphotericin for 20 days. Outcomes: The patient was symptomatically improved after 3 weeks’ treatment. Lessons: With international travel resuming after the pandemic, it becomes imperative that physicians in Australia are aware of this imported disease and its various presentations.

Authors

Institutions

Publication Details

Journal
Asian Pacific Journal of Tropical Medicine
Published
2025-05-01
DOI
https://doi.org/10.4103/apjtm.apjtm_45_25
Primary Topic
Research on Leishmaniasis Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mucocutaneous leishmaniasis in Australia: A case report

Miaron O. Jacob, Carroll S. Wright, Anjali Abraham, Belle Culhane
Asian Pacific Journal of Tropical Medicine
Research on Leishmaniasis Studies
article

Mucocutaneous leishmaniasis in Australia: A case report

Miaron O. Jacob, Carroll S. Wright, Anjali Abraham, Belle Culhane
article en

Abstract

Rationale: Australia is the only inhabited continent, which is not endemic to leishmaniasis. There are some published articles reporting cutaneous leishmaniasis in travellers, immigrants and refugees. However, mucocutaneous leishmaniasis has not been reported previously from the continent. Patient concerns: Lesions were present over the nasal septum and the oropharynx of a 34-year-old healthy non-indigenous male. Diagnosis was delayed as it took multiple biopsies as well as extensive discussions in a multidisciplinary team. Diagnosis: Mucocutaneous leishmaniasis. Interventions: Liposomal Amphotericin for 20 days. Outcomes: The patient was symptomatically improved after 3 weeks’ treatment. Lessons: With international travel resuming after the pandemic, it becomes imperative that physicians in Australia are aware of this imported disease and its various presentations.

Asian Pacific Journal of Tropical MedicineVol. 18(5)
Alice Springs Hospital (AU)
Good health and well-being
Openalex Percentile: Top 84%
Research on Leishmaniasis Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.